A growing number of midlife women are turning to testosterone therapy to address debilitating cognitive symptoms during menopause, according to a report from The Telegraph. Women experiencing severe brain fog, memory problems, and difficulty with basic tasks like counting are increasingly seeking the hormone treatment, challenging traditional approaches to menopausal hormone therapy that have focused primarily on estrogen and progesterone.
The report highlights cases of women struggling with profound cognitive impairment during perimenopause and menopause, with some unable to perform simple mental tasks. These symptoms, often dismissed or misunderstood by healthcare providers, have left many women desperate for solutions beyond conventional hormone replacement therapy. Testosterone, traditionally associated with male health, is now being recognized for its potential role in supporting female cognitive function, energy levels, and overall mental clarity during the menopausal transition.
While estrogen has long been the primary focus of menopausal hormone therapy, research suggests that testosterone also plays important roles in women’s health, including brain function, mood regulation, and energy. Women’s testosterone levels naturally decline with age, and this decrease may contribute to some of the cognitive and psychological symptoms experienced during menopause. However, testosterone therapy for women remains somewhat controversial and is not universally available or approved for cognitive symptoms in many countries.
The trend raises important questions about how menopause-related cognitive symptoms are identified and treated. For women experiencing severe mental fog that affects their daily functioning and quality of life, the potential benefits of testosterone therapy may outweigh concerns about limited long-term data. However, experts emphasize the need for proper medical supervision, appropriate dosing, and continued research into the safety and efficacy of testosterone supplementation in menopausal women, particularly for cognitive indications that fall outside traditional approved uses.
